Operating Profit Veränderung
Abbvie ABBV:US $ 3295M 1422M
Alnylam Pharmaceuticals ALNY:US $ -191.69M 44.95M
Amarin AMRN:US $ -62.83M 34.52M
Amgen AMGN:US $ 2176M 324M
Biogen BIIB:US $ -59.1M 669.8M
Biomarin Pharmaceutical BMRN:US $ 39.15M 98.18M
Cytokinetics CYTK:US $ -10.87M 69.68M
Daiichi Sankyo 4568:JP Y 34382M 85129M
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Esperion Therapeutics ESPR:US $ -52376000 9.39M
Geron GERN:US $ -27.98M 0.7M
Halozyme Therapeutics HALO:US $ 34.06M 41.61M
Heron Therapeutics HRTX:US $ -49.5M 13.42M
Intercept Pharmaceuticals ICPT:US $ -13.36M 3.09M
Intra Cellular Therapies ITCI:US $ -87.92M 15.26M
IONIS PHARMACEUT IONS:US $ -85.51M 28.01M
Merk MRK:US $ 4927M 642M
Minerva Neurosciences NERV:US $ -6.96M 1.02M
Moderna Inc MRNA:US 2.45B 1.78B
Nektar Therapeutics NKTR:US $ -152.84M 36.28M
Pfizer PFE:US $ 12102M 2229M
Ptc Therapeutics PTCT:US $ -92.36M 5.84M
Puma Biotechnology PBYI:US $ 12M 12.77M
Regeneron Pharmaceuticals REGN:US $ 1109.9M 148.6M
Sarepta Therapeutics SRPT:US $ -211.13M 124.25M
Seattle Genetics SGEN:US $ -133.11M 0.06M
United Therapeutics UTHR:US $ 201.8M 84.5M
Vanda Pharmaceuticals VNDA:US $ 3.46M 11.13M



Esperion Therapeutics Betriebsergebnis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2022.